Clinical Outcomes
To assess the efficacy and safety of NOACs versus VKAs in patients with AF and polypharmacy, we divided the included clinical outcomes into primary outcomes (stroke or systemic embolism, major bleeding) and secondary outcomes (ischemic stroke, all-cause death, any bleeding, intracranial bleeding, gastrointestinal bleeding).